Precigen, Inc.
NASDAQ: PGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Helen Sabzevari
- Employees
- 143
- Headquarters
- Germantown, United States
- IPO year
- 2013
- Market cap
- $1.6B
- Website
- https://www.precigen.com
Loading PGEN…
Loading profile data…Frequently asked questions about PGEN
What does Precigen, Inc. (PGEN) do?
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms in...
Where does PGEN trade?
Precigen, Inc. (PGEN) trades on the NASDAQ Global Select.
What sector is PGEN in?
Precigen, Inc. (PGEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Precigen, Inc.?
Helen Sabzevari is the chief executive officer of Precigen, Inc. (PGEN).
Where is Precigen, Inc. headquartered?
Precigen, Inc. is headquartered in United States.
Does PGEN pay a dividend?
Precigen, Inc. (PGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PGEN go public?
Precigen, Inc. (PGEN) completed its initial public offering in 2013.